Valuation PT Ikapharmindo Putramas Tbk

Stocks

End-of-day quote INDONESIA S.E. Other stock markets 2026-06-26			5-day change	1st Jan Change
185.00 ^IDR	+2.21%		-2.63%	-17.41%

04-24	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-16	PT Ikapharmindo Putramas Tbk Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	340,302	411,058	377,364
Change	-	20.79%	-8.2%
Enterprise Value (EV) ¹	445,409	558,217	501,269
Change	-	25.33%	-10.2%
P/E	11.8x	82x	-13.1x
PBR	1.39x	1.67x	1.73x
PEG	3.87x	-1x	0x
Capitalization / Revenue	0.77x	1x	1.04x
EV / Revenue	1.01x	1.35x	1.38x
EV / EBITDA	10.6x	22x	-30.3x
EV / EBIT	14x	31.9x	-20.5x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	2.25	-	-
Rate of return	1.11%	-	-
EPS ²	17.08	2.977	-17.09
Distribution rate	13.2%	-	-
Net sales ¹	441,137	412,069	363,565
EBITDA ¹	41,844	25,345	-16,528
EBIT ¹	31,780	17,514	-24,485
Net income ¹	15,338	5,015	-28,785
Net Debt ¹	105,107	147,159	123,904
Reference price ²	202.00	244.00	224.00
Nbr of stocks (in thousands)	1,684,663	1,684,663	1,684,663
Announcement Date	4/29/24	3/26/25	3/16/26

¹IDR in Million²IDR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PT IKAPHARMINDO PUTRAMAS TBK	-	-	-	-	17.47M
ELI LILLY AND COMPANY	35.2x	12.84x	26.1x	0.57%	1,077B
JOHNSON & JOHNSON	27.22x	6.26x	17.02x	2.1%	613B
ABBVIE INC.	32.17x	7.47x	15.29x	2.73%	448B
ROCHE HOLDING AG	17.9x	4.45x	10.94x	2.98%	332B
ASTRAZENECA PLC	23.72x	4.94x	14x	1.76%	293B
NOVARTIS AG	21.69x	5.59x	13.51x	2.83%	286B
NOVO NORDISK A/S	14.19x	5.21x	10.72x	3.54%	215B
AMGEN INC.	23.3x	6.21x	10.84x	2.81%	193B
GILEAD SCIENCES, INC.	-45.82x	5.53x	30.47x	2.54%	159B
Average	16.62x	6.50x	16.54x	2.43%	361.61B
Weighted average by Cap.	24.44x	7.95x	18.32x	1.97%